Carey Charles P's Form 4 filing
CME Group Inc. (CME) · filed Feb 14, 2022
- Accession no.
- 0001156375-22-000062
- Filed
- Feb 14, 2022
- Trade date
- Feb 10, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $733.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Carey Charles PCIK 0001341358 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2022 | Common Stock Class A | SSaleDisposed | −1,500 | $244.60 | −$366,900 | 9,175 | Indirect | |
| Feb 10, 2022 | Common Stock Class A | SSaleDisposed | −1,500 | $244.11 | −$366,165 | 7,675 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.